Cite
Hürlimann E, Keller L, Patel C, et al. Efficacy and safety of co-administered ivermectin and albendazole in school-aged children and adults infected with Trichuris trichiura in Côte d'Ivoire, Laos, and Pemba Island, Tanzania: a double-blind, parallel-group, phase 3, randomised controlled trial. Lancet Infect Dis. 2021;doi: 10.1016/S1473-3099(21)00421-7.
Hürlimann, E., Keller, L., Patel, C., Welsche, S., Hattendorf, J., Ali, S. M., Ame, S. M., Sayasone, S., Coulibaly, J. T., & Keiser, J. (2021). Efficacy and safety of co-administered ivermectin and albendazole in school-aged children and adults infected with Trichuris trichiura in Côte d'Ivoire, Laos, and Pemba Island, Tanzania: a double-blind, parallel-group, phase 3, randomised controlled trial. The Lancet. Infectious diseases, . https://doi.org/10.1016/S1473-3099(21)00421-7
Hürlimann, Eveline, et al. "Efficacy and safety of co-administered ivermectin and albendazole in school-aged children and adults infected with Trichuris trichiura in Côte d'Ivoire, Laos, and Pemba Island, Tanzania: a double-blind, parallel-group, phase 3, randomised controlled trial." The Lancet. Infectious diseases vol. (2021). doi: https://doi.org/10.1016/S1473-3099(21)00421-7
Hürlimann E, Keller L, Patel C, Welsche S, Hattendorf J, Ali SM, Ame SM, Sayasone S, Coulibaly JT, Keiser J. Efficacy and safety of co-administered ivermectin and albendazole in school-aged children and adults infected with Trichuris trichiura in Côte d'Ivoire, Laos, and Pemba Island, Tanzania: a double-blind, parallel-group, phase 3, randomised controlled trial. Lancet Infect Dis. 2021 Nov 29; doi: 10.1016/S1473-3099(21)00421-7. Epub 2021 Nov 29. PMID: 34856181.
Copy
Download .nbib